Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario

BACKGROUND: Data on vedolizumab (VDZ) use in inflammatory bowel disease (IBD) patients are still limited. We aimed to assess the effectiveness and tolerability of VDZ in a real-life clinical scenario. METHODS: We retrospectively collected data of all consecutive IBD patients who started VDZ from Sep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Zingone, Fabiana, Barberio, Brigida, Compostella, Federico, Girardin, Giulia, D’Incà, Renata, Marinelli, Carla, Marsilio, Ilaria, Lorenzon, Greta, Savarino, Edoardo Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350040/
https://ncbi.nlm.nih.gov/pubmed/32695231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820936536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados